Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jérome Durivault"'
Autor:
Caroline Reynaud, Jacques Pouysségur, Pascal Sommer, Philippe Clézardin, Blandine Deux, Gabrielle S. Le Provost, Géraldine Aimond, Bastien Kaniewski, Jérome Durivault, Frédéric Dayan, Floriane Pez
Supplementary Figure 3 from The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce74cfc26638925ec7ad756e2ed40a15
https://doi.org/10.1158/0008-5472.22388160.v1
https://doi.org/10.1158/0008-5472.22388160.v1
Autor:
Caroline Reynaud, Jacques Pouysségur, Pascal Sommer, Philippe Clézardin, Blandine Deux, Gabrielle S. Le Provost, Géraldine Aimond, Bastien Kaniewski, Jérome Durivault, Frédéric Dayan, Floriane Pez
Supplementary Legends for Figures 1-4 from The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdcaf9efdbfd75c403ec4cc6d165c761
https://doi.org/10.1158/0008-5472.22388154.v1
https://doi.org/10.1158/0008-5472.22388154.v1
Autor:
Caroline Reynaud, Jacques Pouysségur, Pascal Sommer, Philippe Clézardin, Blandine Deux, Gabrielle S. Le Provost, Géraldine Aimond, Bastien Kaniewski, Jérome Durivault, Frédéric Dayan, Floriane Pez
Supplementary Figure 1 from The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bda01ba3e698244f7966bf10ab6514a
https://doi.org/10.1158/0008-5472.22388166
https://doi.org/10.1158/0008-5472.22388166
Autor:
Caroline Reynaud, Jacques Pouysségur, Pascal Sommer, Philippe Clézardin, Blandine Deux, Gabrielle S. Le Provost, Géraldine Aimond, Bastien Kaniewski, Jérome Durivault, Frédéric Dayan, Floriane Pez
Supplementary Figure 4 from The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01bf8ca300ed68487445fed85090dbca
https://doi.org/10.1158/0008-5472.22388157
https://doi.org/10.1158/0008-5472.22388157
Autor:
Caroline Reynaud, Jacques Pouysségur, Pascal Sommer, Philippe Clézardin, Blandine Deux, Gabrielle S. Le Provost, Géraldine Aimond, Bastien Kaniewski, Jérome Durivault, Frédéric Dayan, Floriane Pez
Supplementary Methods from The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d34ae293da5cc72193994ec60336e85
https://doi.org/10.1158/0008-5472.22388151
https://doi.org/10.1158/0008-5472.22388151
Autor:
Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, Olivia Rastoin, Rosie Dawaliby, Thomas Schmitt, Maxence Bourgoin, Héliciane Palenzuela, Anne-Laure Rossi, Damien Ambrosetti, Jerome Durivault, Frederic Luciano, Delphine Borchiellini, Julie Le Du, Leticia Christina Pires Gonçalves, Patrick Auberger, Rachid Benhida, Lisa Kinget, Benoit Beuselinck, Cyril Ronco, Gilles Pagès, Maeva Dufies
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-19 (2024)
Abstract Background In clear cell renal cell carcinoma (ccRCC), first-line treatment combines nivolumab (anti-PD-1) and ipilimumab (anti-CTLA4), yielding long-term remissions but with only a 40% success rate. Our study explored the potential of enhan
Externí odkaz:
https://doaj.org/article/2ff8f539d4e9454cb864905303b22e6e
Autor:
Christopher Montemagno, Jérôme Durivault, Cécile Gastaldi, Maeva Dufies, Valérie Vial, Xingkang He, Damien Ambrosetti, Anna Kamenskaya, Sylvie Negrier, Jean‐Christophe Bernhard, Delphine Borchiellini, Yihai Cao, Gilles Pagès
Publikováno v:
Molecular Oncology, Vol 17, Iss 7, Pp 1379-1401 (2023)
The efficacy of anti‐angiogenic treatment by targeting VEGF/VEGF receptors in metastatic clear cell renal cell carcinoma (ccRCC) varies from patient to patient. Discovering the reasons behind this variability could lead to the identification of rel
Externí odkaz:
https://doaj.org/article/831e3d4234ea451a9319c291c28cd020
Autor:
Aurore Dumond, Etienne Brachet, Jérôme Durivault, Valérie Vial, Anna K. Puszko, Yves Lepelletier, Christopher Montemagno, Marina Pagnuzzi-Boncompagni, Olivier Hermine, Christiane Garbay, Nathalie Lagarde, Matthieu Montes, Luc Demange, Renaud Grépin, Gilles Pagès
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-18 (2021)
Abstract Background Despite the improvement of relapse-free survival mediated by anti-angiogenic drugs like sunitinib (Sutent®), or by combinations of anti-angiogenic drugs with immunotherapy, metastatic clear cell Renal Cell Carcinoma (mccRCC) rema
Externí odkaz:
https://doaj.org/article/4462a16912a7494aaca4c614ed37b5dd
Autor:
Célia Gotorbe, Jérôme Durivault, Willian Meira, Shamir Cassim, Maša Ždralević, Jacques Pouysségur, Milica Vučetić
Publikováno v:
Antioxidants, Vol 11, Iss 12, p 2412 (2022)
Glutathione peroxidase 4 (GPX4) has been reported as one of the major targets for ferroptosis induction, due to its pivotal role in lipid hydroperoxide removal. However, recent studies pointed toward alternative antioxidant systems in this context, s
Externí odkaz:
https://doaj.org/article/6fa95228102c43c2a2c2ebc446150d07
Autor:
Christopher Montemagno, Benjamin Serrano, Jérôme Durivault, Valérie Nataf, François Mocquot, Régis Amblard, Valérie Vial, Cyril Ronco, Rachid Benhida, Maeva Dufies, Marc Faraggi, Gilles Pagès
Publikováno v:
Biochemistry and Biophysics Reports, Vol 27, Iss , Pp 101098- (2021)
The chemokine receptors CXCR1/2 play a key role in the aggressiveness of several types of cancers including head and neck squamous cell carcinomas (HNSCCs). In HNSCCs, CXCR1/2 signaling promotes cell proliferation and angiogenesis leading to tumor gr
Externí odkaz:
https://doaj.org/article/0de8f2a07b134e0aa3203e7045cbdfa2